Response of two mouse tumours to hyperthermia with CCNU or melphalan
- PMID: 7059461
- PMCID: PMC2010966
- DOI: 10.1038/bjc.1982.3
Response of two mouse tumours to hyperthermia with CCNU or melphalan
Abstract
The in vivo response of B16 melanoma and Lewis lung carcinoma to combinations of hyperthermia and graded doses of CCNU or Melphalan was studied. To obtain dose-response curves and quantitative comparisons of different treatments, an agar-colony assay was used to measure survival of cells from excised tumours. For heating experiments, the use of 2 tumours per animal, one heated and one not, allowed all other factors to be kept constant. When tumours were immersed in a water-bath at 43 degrees C for 1 h, Thermal Enhancement Ratios (TER) measured from the slopes of the dose-response curves were up to 1.6 for CCNU and 2.4 for Melphalan. Direct heat killing of about 1 decade was seen for 1 h at 43 degrees C. The anaesthetic Saffan also enhanced drug cell kill; the largest Dose Modifying Factor (2.7) was measured for Melphalan in the Lewis lung tumour. The duration of heating, and waterbath temperature, both influenced the enhancement of cell killing by CCNU, as did the time of excision of tumours between 0 and 3 1/2 h after treatment. There was no difference in effect between 3 1/2 and 24 h. The interaction between heat and CCNU varied if the interval between them was altered. The maximum effect was found if the heat and drug were given in close sequence.
Similar articles
-
Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.Br J Cancer. 1986 Feb;53(2):237-45. doi: 10.1038/bjc.1986.41. Br J Cancer. 1986. PMID: 3954945 Free PMC article.
-
Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.Br J Cancer. 1977 Sep;36(3):313-21. doi: 10.1038/bjc.1977.195. Br J Cancer. 1977. PMID: 921888 Free PMC article.
-
Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.Br J Cancer. 1982 Jul;46(1):109-16. doi: 10.1038/bjc.1982.172. Br J Cancer. 1982. PMID: 7201845 Free PMC article.
-
In vivo combination of misonidazole and the chemotherapeutic agent CCNU.Br J Cancer. 1981 Mar;43(3):367-77. doi: 10.1038/bjc.1981.57. Br J Cancer. 1981. PMID: 7225287 Free PMC article.
-
Hyperthermic tumour-cell devitalization in vivo.Acta Radiol Ther Phys Biol. 1977 May;16(1):1-16. doi: 10.3109/02841867709133928. Acta Radiol Ther Phys Biol. 1977. PMID: 17268 Review.
Cited by
-
Miniature microwave applicator for murine bladder hyperthermia studies.Int J Hyperthermia. 2012;28(5):456-65. doi: 10.3109/02656736.2012.677931. Epub 2012 Jun 12. Int J Hyperthermia. 2012. PMID: 22690856 Free PMC article.
-
Enhanced antitumor efficacy with a combination of hyperthermochemotherapy and thermosensitization with polyamine antimetabolites in nude mice.Jpn J Surg. 1987 Mar;17(2):110-7. doi: 10.1007/BF02470650. Jpn J Surg. 1987. PMID: 3114528
-
Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.Radiat Oncol. 2015 Aug 7;10:165. doi: 10.1186/s13014-015-0462-0. Radiat Oncol. 2015. PMID: 26245485 Free PMC article. Review.
-
Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice.Jpn J Surg. 1985 Mar;15(2):173-6. doi: 10.1007/BF02469749. Jpn J Surg. 1985. PMID: 2409315
-
External Basic Hyperthermia Devices for Preclinical Studies in Small Animals.Cancers (Basel). 2021 Sep 15;13(18):4628. doi: 10.3390/cancers13184628. Cancers (Basel). 2021. PMID: 34572855 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical